Janssen to sell Pfizer antidepressant in Korea; FDA flags off-label claims--for dogs;

> Johnson & Johnson's ($JNJ) Janssen will sell Pfizer's ($PFE) Effexor XR antidepressant in Korea. More

> Arena Pharmaceuticals' ($ARNA) Belviq marketing partner Eisai has upped its sales forces for the obesity drug once again to total about 600 reps. Release

> PharmaMar and Chugai Pharma Marketing have entered a licensing and commercialization agreement in Europe for multiple myeloma drug Aplidin. Release

> BIAL and specialty pharma moksha8 have announced an exclusive marketing deal for epilepsy treatment Zebinix/Exalief in Brazil and Mexico. Release

> Fendix Media has appointed Simon Grime as its new commercial director, putting him in charge of driving the growth of its network of websites for the U.K.'s NHS. Report

> Eli Lilly ($LLY) will sponsor this month's NASCAR Nationwide Series race as part of a multiyear deal. Report

> Purdue Pharma won FDA approval for a new 7.5-mcg/hour dosage of its Butrans Transdermal System. Release

And Finally... Even pharma marketing for dogs can run afoul of the FDA, according to an agency warning letter. More